# BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions

Study · id `cardio:ct-nct02004951` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02004951](<https://clinicaltrials.gov/study/NCT02004951>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02004951

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 186 participants.

## Technical summary

Registry record NCT02004951. Randomized; no masking; primary purpose health services research. Start 2014-03-25 (actual); primary completion 2017-08-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 186 participants (enrolled count; ClinicalTrials.gov record NCT02004951, source copy `cardio:ctgov-nct02004951-2021-02-08`, retrieved 2026-10-31)
- Started: 2014-03-25 (actual) (ClinicalTrials.gov record NCT02004951, source copy `cardio:ctgov-nct02004951-2021-02-08`, retrieved 2026-10-31)
- Primary completion: 2017-08-31 (actual) (ClinicalTrials.gov record NCT02004951, source copy `cardio:ctgov-nct02004951-2021-02-08`, retrieved 2026-10-31)
- Completion: 2020-08-07 (actual) (ClinicalTrials.gov record NCT02004951, source copy `cardio:ctgov-nct02004951-2021-02-08`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT02004951, source copy `cardio:ctgov-nct02004951-2021-02-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02004951-2021-02-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions
- Acronym: BATTLE
- Condition: Peripheral Arterial Disease
- Condition: Femoropopliteal Lesions
- Intervention (Device): Misago RX
- Intervention (Device): Zilver PTX
- Lead sponsor: Nantes University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Nantes University Hospital (`cardio:org-nantes-university-hospital`)

## Provenance

Content hash: 46d1a3c68966b06f275f1996d5b4aeddac66b6b127fd9005faabfdd576d9fde6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
